Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

, TWTR

Twitter

$24.88

-0.535 (-2.11%)

10:32
01/16/18
01/16
10:32
01/16/18
10:32

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying with Broadcom's (AVGO) hostile takeover attempt now analogous to a "gun to the head," Qualcomm management is likely to more aggressively focus on driving shareholder value in order to remain a standalone franchise. 2. Twitter (TWTR) upgraded to Buy from Sell at Aegis with analyst Victor Anthony saying he believes 2018 will be an inflection point in owned and operated advertising for Twitter and he sees a return to double-digit growth in that area in 2019. 3. Procter & Gamble (PG) upgraded to Neutral from Sell at Goldman Sachs with analyst Jason English saying he no longer sees enough downside to estimates to drive material underperformance for the stock. 4. Northrop Grumman (NOC) and Curtiss-Wright (CW) were upgraded to Outperform from Market Perform at Wells Fargo. 5. Ciena (CIEN) was upgraded to Buy from Neutral at Goldman Sachs, while Adtran (ADTN) was upgraded to Neutral from Sell. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

QCOM

Qualcomm

$65.38

-0.05 (-0.08%)

TWTR

Twitter

$24.88

-0.535 (-2.11%)

PG

Procter & Gamble

$90.31

0.7 (0.78%)

NOC

Northrop Grumman

$317.94

2.79 (0.89%)

CW

Curtiss-Wright

$133.63

4.893 (3.80%)

ADTN

Adtran

$19.70

(0.00%)

CIEN

Ciena

$22.69

0.75 (3.42%)

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 21

    Feb

  • 22

    Feb

QCOM Qualcomm
$65.38

-0.05 (-0.08%)

12/05/17
NORL
12/05/17
NO CHANGE
Target $18
NORL
Outperform
Himax may see 'fantastic' growth in 2018, says Northland
Northland analyst Tom Sepenzis says Himax (HIMX) could see "fantastic" growth in 2018 if the 3D sensing opportunity plays out the way that management outlined on its last call. While the growth at its large North American customer remains the easiest to quantify, the real opportunity for growth involves the Android handset vendors and the 3D sensing structured light solution developed with Qualcomm (QCOM), he contends. The analyst reiterates an Outperform rating and $18 price target on Himax shares.
01/16/18
NOMU
01/16/18
UPGRADE
Target $75
NOMU
Buy
Qualcomm upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Romit Shah upgraded Qualcomm (QCOM) to Buy and raised his price target for the shares to $75 from $58. The chipmaker closed Friday down 5c to $65.38. With Broadcom's (AVGO) hostile takeover attempt now analogous to a "gun to the head," Qualcomm management is likely to more aggressively focus on driving shareholder value in order to remain a standalone franchise, Shah tells investors in a research note. He believes potential drivers include closing the NXP Semiconductors (NXPI) acquisition and settling the legal dispute with Apple (AAPL). He sees these catalysts played out over the next two quarters.
12/15/17
JPMS
12/15/17
NO CHANGE
JPMS
JPMorgan sees opportunities in Wireless Semiconductors, prefers Qorvo
JPMorgan analyst Bill Peterson believes the recent pullback in Wireless Semiconductor names, specifically Apple-exposed stocks, creates a good opportunity for investors to take long positions. The analyst sees the most upside in Qorvo (QRVO). He believes fears of production cuts and demand weakness are overblown. The December quarter and outlook for the March quarter are tracking to company expectations that have been built on conservative prospects for smartphone demand, Peterson tells investors in a research note.
12/15/17
OPCO
12/15/17
NO CHANGE
OPCO
Outperform
Broadcom Q2 estimate concerns overblown, says Oppenheimer
After meeting with management, Oppenheimer analyst Rick Schafer believes concerns over the Q2 estimates for Broadcom (AVGO) are overblown. The staggered launches of the two new iPhones creates near-term upside potential, Schafer tells investors in a research note. The company remains his top pick for 2018 with or without Qualcomm (QCOM). He keeps an Outperform rating on the shares with a $315 price target.
TWTR Twitter
$24.88

-0.535 (-2.11%)

01/16/18
01/16/18
UPGRADE
Target $30

Buy
Twitter upgraded to Buy with $30 target at Aegis
As previously reported, Aegis analyst Victor Anthony upgraded Twitter (TWTR) two notches, to Buy from Sell, and set a $30 price target on the stock. Anthony believes 2018 will be an inflection point in owned and operated advertising for Twitter and he sees a return to double-digit growth in that area in 2019. He also sees the potential for improving monthly average user growth, sustained double-digit daily active user growth and thinks the stock could be included in the S&P 500 at some point. Additionally, Anthony sees Facebook's (FB) decision to de-emphasize public content making Twitter a more valuable resource for video and news, making it an even more appealing takeover candidate, he tells investors.
01/11/18
01/11/18
NO CHANGE
Target $27

Overweight
JPMorgan still positive on Twitter despite 41% rally since Q3 report
JPMorgan analyst Doug Anmuth remains positive on Twitter shares despite the 41% rally since the company's Q3 earnings report in late October. While shares are "not cheap" at 13 times 2019 estimated EBITDA, Twitter's increasing traction with both users and advertisers will drive upside to 2018 consensus, Anmuth tells investors in a research note. The analyst calls Twitter a favorite smid-cap idea for 2018 and keeps an Overweight rating on the name with a $27 price target.
01/12/18
BTIG
01/12/18
NO CHANGE
Target $30
BTIG
Buy
Twitter price target raised to $30 from $25 at BTIG
BTIG analyst Richard Greenfield raised his price target on Twitter to $30, saying the company is "is in the early stages of a multi-year turnaround". The analyst notes that the management has refocused on the core product and embraced a video platform for premium content creators, leading to a more engaged user base and a meaningful improvement in sentiment from ad buyers over the past 6 months. Greenfield keeps his Buy rating on Twitter.
01/16/18
AGIS
01/16/18
UPGRADE
AGIS
Buy
Twitter upgraded to Buy from Sell at Aegis
PG Procter & Gamble
$90.31

0.7 (0.78%)

01/16/18
GSCO
01/16/18
UPGRADE
Target $88
GSCO
Neutral
Procter & Gamble upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jason English upgraded Procter & Gamble to Neutral and raised his price target for the shares to $88 from $83. The analyst no longer sees enough downside to estimates to drive material underperformance for the stock. he admits his expectation of a negative estimate revision cycle has failed to materialize.
12/27/17
JEFF
12/27/17
NO CHANGE
JEFF
Nielsen shows improved two-week sales trends, says Jefferies
Jefferies analyst Kevin Grundy says two-week sales growth in U.S. Nielsen channels improved sequentially for key home and personal care companies Colgate-Palmolive (CL), Church & Dwight (CHD) and Clorox (CLX), as well as beverage companies Monster Beverage (MNST), Coca-Cola (KO) and Dr Pepper Snapple (DPS). While overall growth remains tepid, sequential improvement in December for consumer spending, including staples, has been more upbeat, Grundy tells investors in a research note titled "Party Like It's 1999? Not Quite, But US Nielsen HPC/Bevs 2-Week Data Improves." The analyst favors shares of Church & Dwight, Procter & Gamble (PG), Dr Pepper and Monster.
12/13/17
DBAB
12/13/17
INITIATION
Target $101
DBAB
Buy
Procter & Gamble initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Steve Powers started Procter & Gamble with a Buy rating and $101 price target. The company is well positioned after "finally" catching up with market realities," the analyst contends. He views the risk/reward as attractive at current share levels.
11/16/17
JEFF
11/16/17
NO CHANGE
Target $99
JEFF
Buy
Jefferies says P&G 'win-win' thesis intact after Peltz victory
Jefferies analyst Kevin Grundy sees Procter & Gamble shares trading up on news of Nelson Peltz claiming a narrow victory following a proxy recount. The analyst says the development fortifies his "win-win" thesis. Either P&G delivers financial results at least in-line with Street expectations or Peltz likely pushes for greater changes at the company, Gruny tells investors in a research note. He reiterates a Buy rating on Procter & Gamble with a $99 price target.
NOC Northrop Grumman
$317.94

2.79 (0.89%)

12/12/17
12/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Buy from Neutral at Nomura Instinet by analyst Jeffrey Kvaal, who said that better visibility into subscriber growth, rising average revenue per user and cost control will drive earnings growth in 2018. Further, he believes tax reform should also boost the company's earnings. The analyst thinks signs of easing competition may also spur multiple expansion. 2. Northrop Grumman (NOC) upgraded to Overweight from Neutral at JPMorgan by analyst Seth Seifman, who said that more profitable F-35 growth will accelerate in 2018 while management's initial take on the Orbital ATK (OA) deal, including synergies, will prove conservative. He called Northrop his top defense prime pick. 3. Activision Blizzard (ATVI) upgraded to Buy from Neutral at Goldman Sachs by analyst Christopher Merwin, who recommends owning this discounted "high-quality" asset ahead of accelerating earnings growth over the next 2-3 years. Merwin raised Activision's 2019 and 2020 estimates to reflect a robust pipeline of games including Diablo, Overwatch 2, and a Blizzard mobile title, which he does not believe Street estimates fully reflect. 4. Abbott (ABT) upgraded to Outperform from Market Perform at BMO Capital by analyst Joanne Wuensch, who said she is placing the stock on her "Top Picks" list, noting that 2018 will be the "year of execution" with several product launches ahead and acquisitions of Alere and St. June in the past. 5. HCA Healthcare (HCA), Tenet (THC) and Universal Health (UHS) upgraded to Buy from Neutral at Citi by analyst Ralph Giacobbe, who cited a more constructive view on the hospital space. The analyst sees a better volume backdrop in 2018 and low expectations for the sector. He believes hospital stocks offer an attractive upside scenario. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/12/17
JPMS
12/12/17
UPGRADE
JPMS
Overweight
Northrop Grumman upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Northrop Grumman (NOC) to Overweight and raised his price target for the shares to $355 from $317. More profitable F-35 growth will accelerate in 2018 while management's initial take on the Orbital ATK (OA) deal, including synergies, will prove conservative, Seifman tells investors in a research note. He calls Northrop his top defense prime pick.
01/16/18
WELS
01/16/18
UPGRADE
Target $360
WELS
Outperform
Northrop Grumman upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Sam Pearlstein upgraded Northrop Grumman to Outperform and raised his price target for the shares to $360 from $310. Defense stocks with the fastest organic growth are likely to perform best in 2018, Pearlstein tells investors in a research note. He sees Northrop revenue growing from organic growth as well as earnings benefiting from the Orbital ATK acquisition and tax reform.
12/12/17
JPMS
12/12/17
DOWNGRADE
Target $210
JPMS
Neutral
Raytheon downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Seth Seifman downgraded Raytheon ((RTN) to Neutral while raising his price target for the shares to $210 from $190. The analyst cites valuation for the downgrade following the stock's strong performance. He believes Raytheon has well positioned defense franchises but feels Northrop Grumman (NOC) offers more upside.
CW Curtiss-Wright
$133.63

4.893 (3.80%)

01/16/18
WELS
01/16/18
UPGRADE
Target $150
WELS
Outperform
Curtiss-Wright upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Sam Pearlstein upgraded Curtiss-Wright to Outperform and raised his price target for the shares to $150 from $120. The analyst sees the company's earnings and free cash flow growth being driven by the broad industrial recovery, U.S. Navy shipbuilding, and tax reform. He also expects to see additional accretive acquisitions.
10/30/17
10/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) upgraded to Outperform from Market Perform at BMO Capital with analyst Ambrish Srivastava saying the company is starting to execute on delivering operating leverage and also show discipline in its operating model. 2. Conagra Brands (CAG) upgraded to Buy from Hold at Stifel with analyst Christopher Growe citing the stock's valuation, the company's operating profit growth and its optionality to do "aggressive" share repurchase and M&A. 3. Praxair (PX) upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar citing the company's accelerating growth. 4. Bristol-Myers (BMY) upgraded to Buy from Hold at SunTrust with analyst John Boris saying Merck's (MRK) KN-189 data delay to 2019 and withdrawal of its EU 1L NSCLC filing improves the company's competitive position. 5. Curtiss-Wright (CW) upgraded to Buy from Neutral at BofA/Merrill with analyst Kristine Liwag saying it is a significant beneficiary of US Navy submarines and embedded computing. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/17
BOFA
10/30/17
UPGRADE
Target $136
BOFA
Buy
Curtiss-Wright upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Kristine Liwag upgraded Curtiss-Wright to Buy and raised its price target to $136 from $105 saying it is a significant beneficiary of US Navy submarines and embedded computing. The analyst said Curtiss is the sole source coolant pump manufacturer for US Navy nuclear submarines and aircraft carriers and provides off-the-shelf embedded computing board level modules and integrated subsystems. Liwang increased his estimates saying there is a shortage of submarines and the Navy's push to increase procurement provides long-term growth.
12/05/17
BARD
12/05/17
INITIATION
Target $149
BARD
Outperform
Curtiss-Wright initiated with an Outperform at Baird
Baird analyst Peter Arment initiated Curtiss-Wright with an Outperform reflecting his view the company is well positioned for 2018 as all three business segments are poised for solid organic growth. the analyst sees solid defense tailwinds and a series of restructuring initiatives as helping. Arment has a $149 price target on Curtiss-Wright shares.
ADTN Adtran
$19.70

(0.00%)

01/16/18
GSCO
01/16/18
UPGRADE
Target $17
GSCO
Neutral
Adtran upgraded to Neutral on underperformance at Goldman Sachs
Goldman analyst Doug Clark upgraded Adtran to Neutral from Sell following share underperformance, and said the company will benefit from tax reform, and improved US carrier capex. Clark maintained a $17 price target on shares.
01/12/18
NEED
01/12/18
NO CHANGE
Target $22
NEED
Buy
Adtran price target lowered to $22 from $26 at Needham
Needham analyst Richard Valera lowered his price target on Adtran (ADTN) to $22 after the company's "sharply weaker" Q4 pre-announcement and a soft Q1 due to a slowdown at a "Tier 1 customer". Valera says the shortfall is likely the result of a stoppage at CenturyLink's (CTL) vectoring program. Longer term, the analyst keeps his Buy rating on Adtran, with other programs, such as NBN in Australia, AT&T (T) G.Fast, and a possible Verizon (VZ) NGPON win, ramping up in 2018.
01/15/18
GSCO
01/15/18
UPGRADE
GSCO
Neutral
Adtran upgraded to Neutral from Sell at Goldman Sachs
12/29/17
MKMP
12/29/17
NO CHANGE
Target $25
MKMP
Buy
Adtran near-term CenturyLink related weakness to be temporary, says MKM Partners
MKM Partners analyst Michael Genovese lowered his price target on Adtran (ADTN) to $25 from $27 after the company's reduced Q4 guidance due to performance impairment from a tier 1 customer. Genevese says this customer is likely CenturyLink (CTL), which accounted for 24% of Adtran's total sales in 2016. The analyst notes this weakness is likely to be temporary, adding that Adtran performance will likely accelerate into 2019 as the company stands to benefit from 5G spending. Genovese keeps his Buy rating on Adtran.
CIEN Ciena
$22.69

0.75 (3.42%)

12/08/17
BMOC
12/08/17
NO CHANGE
Target $25
BMOC
Outperform
Ciena price target lowered to $25 from $28 at BMO Capital
BMO Capital analyst Tim Long lowered his price target on Ciena to $25 after "mixed" Q4 results and lower than expected Q1 guidance. Long notes that Q4 gross margins of 44.2% were below his forecast and are expected to persist into the next two quarters, but also anticipates more sales and increased market share from new deployments related to these higher costs. The analyst keeps his Outperform rating on Ciena, citing its recent customer wins in APAC and strong traction for WaveServer and WaveLogic Ai as promising.
01/15/18
GSCO
01/15/18
UPGRADE
GSCO
Buy
Ciena upgraded to Buy from Neutral at Goldman Sachs
12/08/17
12/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. D.R. Horton (DHI) downgraded to Market Perform from Outperform at Keefe Bruyette. 2. Ball Corp. (BLL) and Silgan Holdings (SLGN) were downgraded to Underweight from Sector Weight at KeyBanc. 3. Ciena (CIEN) downgraded to Neutral from Overweight at Piper Jaffray with analyst Troy Jensen saying he sees 2018 being a more challenging year for the company. 4. Sigma Designs (SIGM) was downgraded to Hold from Buy at Lake Street, Benchmark, and Craig-Hallum. 5. HollyFrontier (HFC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Doug Leggate citing full valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/18
GSCO
01/16/18
UPGRADE
Target $27
GSCO
Buy
Ciena upgraded to Buy on imroving capex at Goldman Sachs
Goldman analyst Doug Clark upgraded Ciena to Buy and raised its price target to $27 from $24 telling investors it is a key beneficiary to more supportive carrier capex spending in 2018, expects the company to continue to take market share given differentiated technology, and for investors to lower expectations and adjust for a decelerating optical market growth.

TODAY'S FREE FLY STORIES

ABT

Abbott

$62.84

1.05 (1.70%)

, MS

Morgan Stanley

$49.20

0.29 (0.59%)

20:25
07/17/18
07/17
20:25
07/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$62.84

1.05 (1.70%)

MS

Morgan Stanley

$49.20

0.29 (0.59%)

USB

U.S. Bancorp

$51.29

-0.01 (-0.02%)

TXT

Textron

$66.81

0.14 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

ADTN

Adtran

$16.05

0.1 (0.63%)

20:14
07/17/18
07/17
20:14
07/17/18
20:14
Earnings
Adtran reports Q2 adjusted EPS (10c), two estimates (32c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

, ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

20:09
07/17/18
07/17
20:09
07/17/18
20:09
Hot Stocks
FS Bancorp to merge with Anchor Bancorp in $77M deal »

FS Bancorp (FSBW) and…

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.41

-1.19 (-4.31%)

20:06
07/17/18
07/17
20:06
07/17/18
20:06
Hot Stocks
Breaking Hot Stocks news story on Canopy Growth  »

Greenstar Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$356.95

0.94 (0.26%)

19:10
07/17/18
07/17
19:10
07/17/18
19:10
Hot Stocks
Boeing awarded $3.9B government contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Martin…

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:38
07/17/18
07/17
18:38
07/17/18
18:38
Hot Stocks
BHP Billiton sees FY19 copper equivalent output broadly in line with FY18 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:35
07/17/18
07/17
18:35
07/17/18
18:35
Hot Stocks
BHP Billiton reports Q4 petroleum production 49 MMBOE, down 6% »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

18:31
07/17/18
07/17
18:31
07/17/18
18:31
Downgrade
Clorox rating change at Goldman Sachs »

Clorox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27
Hot Stocks
NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger »

NCI Building Systems and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

, AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

18:16
07/17/18
07/17
18:16
07/17/18
18:16
Earnings
America Movil reports Q2 operating profit MXN32.6M, up 4.8% from last year »

Reports Q2 revenue…

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,844.00

21.98 (1.21%)

18:08
07/17/18
07/17
18:08
07/17/18
18:08
Recommendations
Amazon.com analyst commentary at Piper Jaffray »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

, BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

18:06
07/17/18
07/17
18:06
07/17/18
18:06
Hot Stocks
Berkshire Hathaway amends share repurchase program »

The Board of Directors of…

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$60.10

-0.5 (-0.83%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Earnings
Pinnacle Financial reports Q2 EPS $1.15, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Sep

CHDN

Churchill Downs

$304.60

1.1 (0.36%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Hot Stocks
Churchill Downs receives approval to increase historical racing machines »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CE

Celanese

$110.22

1.6 (1.47%)

18:01
07/17/18
07/17
18:01
07/17/18
18:01
Hot Stocks
Celanese announces acetic acid price increases in Asia »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BLK

BlackRock

$504.89

1.14 (0.23%)

17:51
07/17/18
07/17
17:51
07/17/18
17:51
Hot Stocks
BlackRock raises quarterly dividend to $3.13 from $2.88 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$12.47

0.57 (4.79%)

17:45
07/17/18
07/17
17:45
07/17/18
17:45
Conference/Events
Dicerna management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

, GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

17:44
07/17/18
07/17
17:44
07/17/18
17:44
Periodicals
Google faces record EU fine over Android dominance, FT reports »

Alphabet's Google…

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 18

    Sep

  • 28

    Oct

BA

Boeing

$356.95

0.94 (0.26%)

17:39
07/17/18
07/17
17:39
07/17/18
17:39
Periodicals
Breaking Periodicals news story on Boeing »

Boeing awarded $3.9B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GWR

Genesee & Wyoming

$80.62

-0.88 (-1.08%)

17:34
07/17/18
07/17
17:34
07/17/18
17:34
Hot Stocks
Genesee & Wyoming reports June total traffic down 1.2% »

G&W's total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BLMN

Bloomin' Brands

$20.79

0.07 (0.34%)

17:19
07/17/18
07/17
17:19
07/17/18
17:19
Recommendations
Bloomin' Brands analyst commentary at Tigress Financial »

Current pullback in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TLYS

Tilly's

$15.35

0.21 (1.39%)

17:13
07/17/18
07/17
17:13
07/17/18
17:13
Syndicate
Breaking Syndicate news story on Tilly's »

Tilly's files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUUU

Energy Fuels

$2.30

0.03 (1.32%)

, URG

UR-Energy

$0.66

-0.0068 (-1.02%)

17:10
07/17/18
07/17
17:10
07/17/18
17:10
Periodicals
Trump admin plans to probe uranium imports, may lead to tariffs, Bloomberg says »

The Trump administration…

UUUU

Energy Fuels

$2.30

0.03 (1.32%)

URG

UR-Energy

$0.66

-0.0068 (-1.02%)

CCJ

Cameco

$10.93

0.16 (1.49%)

WWR

Westwater Resources

$0.37

-0.0023 (-0.62%)

UEC

Uranium Energy

$1.55

-0.015 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

BPI

Bridgepoint Education

$7.01

0.215 (3.17%)

17:08
07/17/18
07/17
17:08
07/17/18
17:08
Hot Stocks
Bridgepoint Education receives approval to merge subsidiary institutions »

Bridgepoint Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.